US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 17, 2013 (13 years ago)

Belladonna Alkaloids/PB

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.

What was recalled

Belladonna Alkaloids/PB (Belladonna Alkaloids / Phenobarbital) Tablets Phenobarbital USP 16.2 mg, Hyoscyamine Sulfate 0.1037 mg, Atropine Sulfate 0.0194 mg, Scopolamine Hydrobromide 0.0065 mg 30-count bottle (NDC 54868-0031-04), Rx only, Repackaged and distributed by Physicians Total Care, Inc. Tulsa, OK 74146.

Recalling firm
Physicians Total Care, Inc.
NDC code
54868-0031-04
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-826-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Atropine recalls

See all
Class III · Low risk Terminated

Atropine Sulfate Ophthalmic Solution

Reason Failed Impurities/Degradation Specifications

Somerset Therapeutics LLC NDC 70069-716-01 D-0169-2025
Class I · High risk Ongoing

Atropine Sulfate Injection

Reason Presence of Particulate Matter; identified as glass

Pfizer Inc. NDC 0409-4911-11 D-0235-2024
Class II · Moderate risk Terminated

Atropine Sulfate Injection

Reason Presence of Particulate Matter: Particulate matter identified as fiber.

Accord Healthcare, Inc. NDC 16729-512-43 D-0917-2023
Class II · Moderate risk Ongoing

Atropine Sulfate Ophthalmic Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0779-2023
Class III · Low risk Ongoing

Atropine Sulfate Ophthalmic Solution

Reason Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

Akorn, Inc. D-0265-2023